Measurement of endocrine activity (SET2,3) related to prognosis and prediction of benefit from dose-dense chemotherapy in estrogen receptor-positive (ER+) cancer: correlative analysis of C9741 (Alliance).
- Citation:
- J Clin Oncol vol 40 (16 supp;) 505
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster/Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4208
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171; Breast Cancer Research Foundation (BCRF-158)
- Corr. Author:
- Authors:
- Otto Metzger Karla Ballman Jordan Campbell Minetta Liu Jennifer Ligibel Mark Watson Eveline Chen Lili Du W. Fraser Symmans
- Networks:
- LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-TX035
- Study
- CALGB-9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: